Today is June 02, 2024. All times in Eastern Daylight Time.
Bihar collabora con Bidgely per ridurre i furti di energia e le perdite di ricavi tramite l'analisi dei dati alimentata dall'IA
06/01/2024 - 03:42 PM
BUSINESS WIRE
Accutar Biotechnology、ASCO 2024にてER +/ HER2-乳がん患者におけるAC699単剤療法の第1相試験データを発表
06/01/2024 - 02:42 PM
BUSINESS WIRE
Accutar Biotechnology在2024年ASCO年会上公布了在ER+/HER2-乳腺癌患者中开展AC699单一疗法一期试验的数据
06/01/2024 - 02:30 PM
BUSINESS WIRE
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
06/01/2024 - 02:25 PM
BUSINESS WIRE
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
06/01/2024 - 02:20 PM
BUSINESS WIRE
ADSK Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Autodesk, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
06/01/2024 - 10:01 AM
BUSINESS WIRE
First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
06/01/2024 - 10:00 AM
BUSINESS WIRE
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
06/01/2024 - 10:00 AM
BUSINESS WIRE
"Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
06/01/2024 - 10:00 AM
BUSINESS WIRE
Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
06/01/2024 - 09:30 AM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1498
Next »